Trials / Completed
CompletedNCT04661423
Use of RDS MultiSense® in Post-ICU Patients in the COVID-19 Era
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- IHU Strasbourg · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this clinical study, the investigators will compare vital parameters measurements obtained using continuous data from reference monitors and continuous wireless MultiSense® monitoring patch in 60 post-ICU (Intensive Care Unit) patients and over 7 days.
Detailed description
The MultiSense® strip is a unique, band aid-sized, clinical signal quality, connected strip for real-time monitoring of cardio-respiratory parameters. The MultiSense® strip measures in real-time, remotely and continuously 11 clinical key-indicators by being attached to the patient thorax: ECG trace, heart rate, oxygen saturation (SpO2), respiratory rate and relative respiration depth, pulse transit time, plethysmographic trace, perfusion index, skin temperature, physical activity and body position. Designed to be worn continuously for at least seven days, the patient can keep the patch during his sleep or in the shower. The aim of this study is to determine the quality of measurements of clinical signs provided by MultiSense® strip in comparison to measurements made with conventional medical devices in the hospital setting, in terms of accuracy, connectivity, generation of artifactual data and stability of data transmission. The study population includes 60 patients transferred to post-ICU units for a minimum of 5 days. Once in the post-ICU unit, the MultiSense® strip will be attached on patient's thorax. The monitoring will last between 5 to 7 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Remote Automated Monitoring System | The patient will be monitored with conventional monitoring devices as well as the MultiSense patch. |
Timeline
- Start date
- 2021-09-02
- Primary completion
- 2025-03-02
- Completion
- 2025-03-02
- First posted
- 2020-12-10
- Last updated
- 2025-05-01
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04661423. Inclusion in this directory is not an endorsement.